Astrazeneca Pharma India Reports Strong Q4 Results, Highlights Operational Efficiency Gains
Astrazeneca Pharma India has announced strong financial results for the quarter ending December 2024, with significant growth in key metrics. Profit Before Tax reached Rs 67.59 crore, while Net Sales hit a record Rs 440.29 crore. The company also reported improved operational efficiency, reflected in its Operating Profit and margin.
Astrazeneca Pharma India has reported its financial results for the quarter ending December 2024, showcasing a very positive performance. The company has experienced notable growth in several key metrics, reflecting a robust operational environment.The Profit Before Tax less Other Income (PBT) reached Rs 67.59 crore, marking a significant increase compared to the average of the previous four quarters. This upward trend is mirrored in the Net Sales, which hit a record high of Rs 440.29 crore, demonstrating consistent growth over the last five quarters. Additionally, the Profit After Tax (PAT) stood at Rs 55.48 crore, also showing a substantial rise from prior averages.
Astrazeneca Pharma India's Operating Profit (PBDIT) reached its highest level in the last five quarters at Rs 76.99 crore, indicating improved operational efficiency. The Operating Profit Margin also saw a positive shift, recorded at 17.49%, further underscoring the company's enhanced efficiency.
In light of these developments, Astrazeneca Pharma India has undergone an adjustment in its evaluation, reflecting the positive trends observed in its financial performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
